CP Rail cuts jobs to keep pace with CN
Article Abstract:
Canadian Pacific Railway Ltd. (CPR) reduces workforce in order to remain competitive with Canadian National Railway Co. The details of CPR's proposal are presented.
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2006
Personnel administration, Human resource management, Company personnel management
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
CPR signals a switch in strategy to narrow competitive gap with CN
Article Abstract:
The reasons behind the restructuring efforts of Canadian Pacific Railway Ltd. are presented.
Publisher: Bell Globemedia Interactive
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2006
Organizational history, Company restructuring/company reorganization, Reorganization and restructuring, Company organization
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Canada, Railroads, CP, Canadian Pacific Railway Ltd.
Similar abstracts:
- Abstracts: Executive decision: to make inroads against RIM, Palm steals its strategy. Chinese firm paints Big Blue a little red: Lenovo buys PC business of U.S. icon IBM
- Abstracts: Steel maker forged fate with union deals. Investors seek funds from Stelco to cover legal fees. Stelco bondholders lose court appeal
- Abstracts: New battle of Alberta: pipelines. First Calgary to go it alone
- Abstracts: CanWest posts loss on TV unit, writedown. CanWest faced with stumble down under. Cogeco's new phone service has 'snowball effect.'
- Abstracts: Patent disputes: The issues. Investing for a Profit and a Daughter's Health. Rivals Laying Siege to Amgen's Near Monopoly in Anemia Drugs
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.